BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 38390187)

  • 1. CRISPR/Cas-based nucleic acid detection strategies: Trends and challenges.
    Zhou J; Li Z; Seun Olajide J; Wang G
    Heliyon; 2024 Feb; 10(4):e26179. PubMed ID: 38390187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of CRISPR-Mediated Nucleic Acid Detection Technologies and Their Applications in the Livestock Industry.
    Zhang X
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid.
    Li X; Zhong J; Li H; Qiao Y; Mao X; Fan H; Zhong Y; Imani S; Zheng S; Li J
    Front Mol Biosci; 2023; 10():1260883. PubMed ID: 37808520
    [No Abstract]   [Full Text] [Related]  

  • 4. Advancements in CRISPR-Based Biosensing for Next-Gen Point of Care Diagnostic Application.
    Kumaran A; Jude Serpes N; Gupta T; James A; Sharma A; Kumar D; Nagraik R; Kumar V; Pandey S
    Biosensors (Basel); 2023 Jan; 13(2):. PubMed ID: 36831968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Mechanisms Underlying CRISPR/Cas-Based Assays for Nucleic Acid Detection.
    Antropov DN; Stepanov GA
    Curr Issues Mol Biol; 2023 Jan; 45(1):649-662. PubMed ID: 36661529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating CRISPR/Cas within isothermal amplification for point-of-Care Assay of nucleic acid.
    Zhang L; Jiang H; Zhu Z; Liu J; Li B
    Talanta; 2022 Jun; 243():123388. PubMed ID: 35303554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal amplification and output of CRISPR/Cas-based biosensing systems: A review.
    Wang SY; Du YC; Wang DX; Ma JY; Tang AN; Kong DM
    Anal Chim Acta; 2021 Nov; 1185():338882. PubMed ID: 34711321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence Signal-Readout of CRISPR/Cas Biosensors for Nucleic Acid Detection.
    Huang Z; Liu S; Pei X; Li S; He Y; Tong Y; Liu G
    Biosensors (Basel); 2022 Sep; 12(10):. PubMed ID: 36290917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas systems for the detection of nucleic acid and non-nucleic acid targets.
    Su W; Li J; Ji C; Chen C; Wang Y; Dai H; Li F; Liu P
    Nano Res; 2023 Mar; ():1-14. PubMed ID: 37359078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies.
    Aman R; Mahas A; Mahfouz M
    ACS Synth Biol; 2020 Jun; 9(6):1226-1233. PubMed ID: 32159950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas-based techniques for pathogen detection: Retrospect, recent advances, and future perspectives.
    Huang T; Zhang R; Li J
    J Adv Res; 2023 Aug; 50():69-82. PubMed ID: 36367481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ultrasensitive and specific point-of-care CRISPR/Cas12 based lateral flow biosensor for the rapid detection of nucleic acids.
    Mukama O; Wu J; Li Z; Liang Q; Yi Z; Lu X; Liu Y; Liu Y; Hussain M; Makafe GG; Liu J; Xu N; Zeng L
    Biosens Bioelectron; 2020 Jul; 159():112143. PubMed ID: 32364943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital Recombinase Polymerase Amplification, Digital Loop-Mediated Isothermal Amplification, and Digital CRISPR-Cas Assisted Assay: Current Status, Challenges, and Perspectives.
    Yin W; Zhuang J; Li J; Xia L; Hu K; Yin J; Mu Y
    Small; 2023 Dec; 19(49):e2303398. PubMed ID: 37612816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas systems for diagnosing infectious diseases.
    Kostyusheva A; Brezgin S; Babin Y; Vasilyeva I; Glebe D; Kostyushev D; Chulanov V
    Methods; 2022 Jul; 203():431-446. PubMed ID: 33839288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules.
    Feng W; Newbigging AM; Tao J; Cao Y; Peng H; Le C; Wu J; Pang B; Li J; Tyrrell DL; Zhang H; Le XC
    Chem Sci; 2021 Mar; 12(13):4683-4698. PubMed ID: 34163728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-cas technology: A key approach for SARS-CoV-2 detection.
    Fang L; Yang L; Han M; Xu H; Ding W; Dong X
    Front Bioeng Biotechnol; 2023; 11():1158672. PubMed ID: 37214290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas Systems towards Next-Generation Biosensing.
    Li Y; Li S; Wang J; Liu G
    Trends Biotechnol; 2019 Jul; 37(7):730-743. PubMed ID: 30654914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gold Nanomaterials-Implemented CRISPR-Cas Systems for Biosensing.
    Fu R; Xianyu Y
    Small; 2023 May; 19(21):e2300057. PubMed ID: 36840654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review on the Mechanism and Applications of CRISPR/Cas9/Cas12/Cas13/Cas14 Proteins Utilized for Genome Engineering.
    Hillary VE; Ceasar SA
    Mol Biotechnol; 2023 Mar; 65(3):311-325. PubMed ID: 36163606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas systems mediated biosensing and applications in food safety detection.
    Liu J; Wu D; Chen J; Jia S; Chen J; Wu Y; Li G
    Crit Rev Food Sci Nutr; 2024; 64(10):2960-2985. PubMed ID: 36218189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.